臨床試験と医療の統合: 分裂した家を修復する
Derek C Angus1,2, Alison J Huang3, Roger J Lewis1,4
1JAMA , Chicago, Illinois.
JAMA
|June 3, 2024
まとめ
臨床試験と医療の統合は 患者のケアを改善するために不可欠です シロへの対処とデータ統合の強化は,研究成果の実用化を加速させることができます.
科学分野:
- 医療サービス研究
- 臨床試験の方法論
- 医療情報学
背景:
- 最適な医療提供には 知識の生成,拡散,利用の継続的なサイクルが必要です
- ランダム化臨床試験 (RCT) は有効な介入の決定に不可欠ですが,医療提供への統合には課題があります.
- 臨床試験と医療提供の間の シロ目標とインフラストラクチャは 患者のニーズへの対応を制限し 根拠に基づいた実践の採用を遅らせます
研究 の 目的:
- 臨床試験と医療提供企業を よりよく統合する必要性を強調する.
- 臨床試験と医療提供のエコシステムにおける改善の鍵となる分野を特定する.
- 医療の最適化における デジタルヘルスの進歩と政策の調整の可能性を強調する.
主な方法:
- 資源豊かな国における臨床試験と医療制度の分離の分析
- 改善が必要な4つの主要な分野を特定する. 規制,試験設計の効率化,電子医療記録の統合,利害関係者の調整.
- 既存の課題と解決策の見直し,立法と財政的なインセンティブを含む.
主要な成果:
- 臨床試験と医療の提供は しばしば別々の実体として機能し,生成された知識とその実施の間のギャップにつながります.
- 規制の明確性,臨床試験の統計的・物流的効率性,健康データの相互運用性を大幅に改善する必要がある.
- 利害関係者をインセンティブを通じて 連携させることは 成功したソリューションを拡大するために不可欠です
結論:
- 知識の生成 (臨床試験) と実施 (医療の提供) の間の断絶は,最適な患者のケアを妨げています.
- この2つの分野を統合することは,医療の提供の改善を加速させるのに不可欠です.
- 規制,方法論,データ,インセンティブに関する課題に取り組むことは,このギャップを埋めるための鍵です.
関連する概念動画
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:27Nursing Clinical Information System
765
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
765
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K